ZoeNCure Therapeutics Secures License for Novel Antibody Platform from Styx Biotechnologies to Advance Next-Generation ADCs for Liver Cancer
Sep 03, 2026
New Delhi [India], September 3: ZoeNCure Therapeutics Pvt. Ltd., an oncology biotechnology company based in New Delhi, today announced a strategic licensing agreement with...